Enfermedad tromboembólica venosa104. Few JW, Marcus JR, Placik OJ. Deep vein thrombosis prophylaxisin the mo<strong>de</strong>rate-to-high-risk patient un<strong>de</strong>rgoing lower extremityliposuction. Plast Reconstr Surg 1999;104(1):309-10.105. Comerota AJ, Chouhan V, Harda RN, et al. The fi brinolyticeffects of intermittent pneumatic compression: mechanism ofenhanced fi brinolysis. Ann Surg 1997;226:306-13.106. Oates-Whitehead RM, D’Angelo A, Mol B. Anticoagulant andaspirin prophylaxis for preventing thromboembolism after majorgynaecological surgery. The Cochrane library. The CochraneCollaboration, 2005.107. Baykal C, Al A, Demirtas E, Anyhan A. Comparison of enoxaparinand standard heparin in gynecologic oncologic surgery:a randomized prospective double-blind clinical study. Eur JGynaecol Oncol 2001;22:127-30.108. Clagett GP, Reisch JS. Prevention of venous thromboembolismin general surgical patients: results of meta-analysis. Ann Surg1998;208:227-40.109. Mismetti P, Laporte S, Darmon J-Y, Buchmuller A, DecoususH. Mismetti P: meta-analysis of low molecular weight heparin inthe prevention of venous thromboembolism in general surgery.Br J Surg 2001;88:913-30.110. Bergqvist D, Agnelli G, Cohen AT, et al. Duration of prophylaxisagainst venous thromboembolism with enoxaparin after surgeryfor cancer. N Engl J Med 2002;346(13):975-80.111. Society of American Gastrointestinal Endsocopic Surgeons:Global statement on <strong>de</strong>ep venous thrombosis prophylaxisduring laparoscopic surgery. www.sages.org/sg_pub_c.html112. Mohr DN, Silversteins MD, Heit JA, et al. The venous stasissyndrome after venous thrombosis or pulmonary embolism;a populatim based study 112. Mayo Clinic Proceedings2006;75(12):1249-56.113. Sapala JA, Wood MH, Schuhknecht MP, Sapala MA. Fatal pulmonaryembolism after bariatric operations for morbid obesity:a 24-year retrospective analysis. Obes Surg 2003;13:819-25.114. Rosenthal D, Willons ED, Lai KM, Bikk A, Hen<strong>de</strong>rson VJ. Retrievableinferior vena cava fi lters: Initial clinical results. AnnVasc Surg 2006;20:157-65.115. Sauerland S, Angrisani L, Belachew M, et al. Obesity surgery:evi<strong>de</strong>nce-based gui<strong>de</strong>lines of the European Association forEndoscopic Surgery (EAES). Surg Endosc 2005;19:200-21.116. Gonzalez QH, Tishler DS, Plata-Munoz JJ, et al. Inci<strong>de</strong>nce ofclinically evi<strong>de</strong>nt <strong>de</strong>ep venous thrombosis after laparoscopicRoux-en-Y gastric bypass. Surg Endosc 2004;18:1082-4.117. Choudhary AM, Graver D, Nelson A, et al. Current practicesin the prophylaxis of venous thromboembolism in bariatricsurgery. Obes Surg 2000;10:7-14.118. Bounameaux H, Didier D, Polat O. Antithrombotic prophylaxisin patients un<strong>de</strong>rgoing laparoscopic cholecystectomy. ThrombRes 1997;86:271-3.119. Samuelsson E, Hagg S. Inci<strong>de</strong>nce of venous thromboembolismin young Swedish women and possibly preventablecases among combined oral contraceptive users. Acta ObstetGynecol Scand 2004;83:674-81.120. Kakkar VV, Stringer MD. Prophylaxis of venous thromboembolism.World J Surg 1990;14:670-8.121. Kearon C. Duration of venous thromboembolism prophylaxisafter surgery. Chest 2003;124:386-92.122. Macouillard G, Castagnera L. Claviere JP, et al. Comparativeeffi cacy of two dosages of a low molecular weight heparinfor prevention of <strong>de</strong>ep venous thrombosis in spinal surgery.Thromb Haemost 1995;73:979.123. Norwood SH, McAuley CE, Berne JD, et al. A potentiallyexpan<strong>de</strong>d role for enoxaparin in preventing venous thromboembolismin high risk blunt trauma patients. J Am Coll Surg2001;192(2):161-7.124. Goldhaber SZ, Dunn K, Gerhard-Herman M, Park JK, McLBlack P. Low rate of venous thromboembolism after craniotomyfor brain tumor using multimodality prophylaxis. Chest2002;122:1933-7.125. Clagett GP, An<strong>de</strong>rson FA, Heit J, et al. Prevention of venousthromboembolism. Chest 1995;108(4Suppl):312S-34S.126. Raschke RA, Gollihare B, Peirce JC. The effectiveness of implementingthe weight-based heparin nomogram as a practicegui<strong>de</strong>line. Arch Intern Med 1996;156:1645-9.127. Ansell J, Hirsch J, Poller L, et al. The pharmacology andmanagement of vitamin K antagonist. The seventh <strong>AC</strong>CPconference on antithrombotic and thrombolytic therapy. Chest2004;136:204S-33S.128. Westling A, Bergqvist D, Bostrom A, Karacagil S, GustavssonS. Inci<strong>de</strong>nce of <strong>de</strong>ep venous thrombosis in patients un<strong>de</strong>rgoingobesity surgery. World J Surg 2002;26:470-3.129. Khansanaria S, Dennis JW, Vel<strong>de</strong>nz HC, Butcher JL, HartlanL. Prophylactic Greenfi eld fi lter placement in selected highrisk trauma patients. J Vascular Surg 1995;22:231-5;discussion235.ANEXOSignos y síntomasDisnea 80%Taquipnea > 20 x min 80 a 90%Dolor torácico 60 a 80%Taquicardia > 100 x min 60 a 80%Tos 50%Estertores 50%Fiebre 20-50%Hemoptisis 20 a 30%Componente pulmonar <strong>de</strong>l segundo ruido acentuado50 a 60%Soplo <strong>de</strong> insuficiencia tricuspí<strong>de</strong>a
ConsensoInversión <strong>de</strong> la onda T <strong>de</strong> V1 a V4 45 85% en tromboemboliapulmonar graveSI, QIII, TIII 30% en tromboembolia pulmonargraveP pulmonale 30% en tromboembolia pulmonargraveNormal
Change language